Eduardo E. Montalvo-Javé
Hospital General de México
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eduardo E. Montalvo-Javé.
Case Reports in Gastroenterology | 2012
Francisco Emilio Ferreira-Aparicio; Rafael Gutiérrez-Vega; Yolanda Gálvez-Molina; Patricia Ontiveros-Nevares; César Athié-Gutiérrez; Eduardo E. Montalvo-Javé
A diverticulum is a bulging sack in any portion of the gastrointestinal tract. The most common site for the formation of diverticula is the large intestine. Small intestine diverticular disease is much less common than colonic diverticular disease. The most common symptom is non-specific epigastric pain and a bloating sensation. Major complications include diverticulitis, gastrointestinal bleeding, acute perforation, pancreatic or biliary (in the case of duodenal diverticula) disease, intestinal obstruction, intestinal perforation, localized abscess, malabsorption, anemia, volvulus and bacterial overgrowth. We describe the clinical case of a 65-year-old female patient with a diagnosis on hospital admittance of acute appendicitis and a intraoperative finding of diverticular disease of the small intestine, accompanied by complications such as intestinal perforation, bleeding and abdominal sepsis. This was surgically treated with intestinal resection and ileostomy and a subsequent re-intervention comprising perforation of the ileostomy and stomal remodeling. The patient remained hospitalized for approximately 1 month with antibiotics and local surgical wound healing, as well as changes in her diet with food supplements and metabolic control. She showed a favorable clinical evolution and was dismissed from the hospital to her home. We include here a discussion on trends in medical and surgical aspects as well as early handling or appropriate management to reduce the risk of fatal complications.
European Journal of Cancer | 2016
Eduardo E. Montalvo-Javé; Marisela Olguín-Martínez; Diego Rolando Hernández-Espinosa; Lourdes Sánchez-Sevilla; Edgar Mendieta-Condado; Luis F. Oñate-Ocaña; Tomás Escalante-Tatersfield; Agustín Echegaray-Donde; Juan Manuel Ruiz-Molina; Miguel F. Herrera; Julio Morán; Rolando Hernández-Muñoz
BACKGROUNDnGastric cancer is one of the main causes of global mortality. Here, reactive oxygen species (ROS) could largely contribute to gastric carcinogenesis. Hence, the present work was aimed to assess the role of ROS, oxidant status, NADPH oxidases (NOXs) expression, during human gastric adenocarcinoma.nnnMETHODSnWe obtained subcellular fraction from samples of gastric mucosa taken from control subjects (n = 20), and from 40 patients with gastric adenocarcinoma, as well as samples of distant areas (tumour-free gastric mucosa).nnnRESULTSnParameters indicative of lipid peroxidation and cell proliferation were selectively increased in both tumour-free and in cancerous gastric mucosa, despite of glutathione (GSH) content, glutathione reductase (GR) and superoxide dismutase (SOD) activities were increased in the adenocarcinoma. These high levels of antioxidant defences inversely correlated with down-regulated expression for NOX2 and 4; however, over-expression of NOX1 occurred with increased caspase-3 activity and overexpressed checkpoint 1 (MDC1) and cyclin D1 proteins. In the tumour-free mucosa an oxidant stress took place, without changing total GSH but with decreased activities for GR and mitochondrial SOD; moreover, over-expression of checkpoint 1 (MDC1) correlated with lower NOX2 and 4 expression in this mucosa.nnnCONCLUSIONSnChronically injured gastric mucosa increases lipoperoxidative events and cell proliferation. In the adenocarcinoma, cell proliferation was further enhanced, oxidant stress decreased which seemed to be linked to NOX1, MDC1 and cyclin D1 over-expression, but with a lower NOXs activity leading a low tone of ROS formation. Therefore, our results could be useful for early detection and treatment of gastric adenocarcinoma.
Transplant International | 2011
Eduardo E. Montalvo-Javé; Jose A. Ortega-Salgado; Andrés Castell; Daniel Carrasco-Daza; David Jay; Roberto Gleason; Eduardo Muñoz; César Montalvo-Arenas; Rolando Hernández-Muñoz; Enrique Piña
The present study was aimed to assess the effect of protein carbonylation (PC) in hepatic cells and effects of nonsteroidal anti‐inflammatory drugs (NSAIDs) on indicators of tissue damage induced by liver ischemia–reperfusion injury (LIRI). Warm ischemia was performed by partial vascular occlusion during 90u2003min in Wistar rats. In serum, we determined the catalytic activity of Alanine Aminotransferase, Aspartate Aminotransferase, Lacticate Dehydrogenase, and Ornithine Carbamoyltransferase. In liver samples, we studied cellular alterations by means of histologic studies, lipid peroxidation, PC by immunohistochemistry, apoptosis and reactive oxygen species in bile by electron paramagnetic resonance. Based on PC data, sinusoidal endothelial cells (SEC) and Kupffer cells (KC) were the first to exhibit LIRI‐associated oxidative damage and prior to parenchymal cells. Administration of piroxicam or meloxicam during the pre‐ischemic period produced a highly significant decrease in all studied injury indicators. No significant differences were revealed between the protective action of the two drugs. The data shown here suggest the potential use of NSAIDs such as piroxicam or meloxicam in minimizing ischemic event‐caused damage in liver. We also propose that PC may be employed as an adequate tool to assess tissue damage after oxidative stress.
Euroasian Journal of Hepato-Gastroenterology | 2017
Alan Isaac Valderrama-Treviño; Baltazar Barrera-Mera; Jesús Carlos Ceballos-Villalva; Eduardo E. Montalvo-Javé; Hasan Ozkan
The liver is the most common site of metastasis in patients with colorectal cancer due to its anatomical situation regarding its portal circulation. About 14 to 18% of patients with colorectal cancer present metastasis at the first medical consultation, and 10 to 25% at the time of the resection of the primary colorectal cancer. The incidence is higher (35%) when a computed tomography (CT) scan is used. In the last decades, a significant increase in the life expectancy of patients with colorectal cancer has been achieved with different diagnostic and treatment programs. Despite these improvements, the presence of metastasis, disease recurrence, and advanced local tumors continue to remain poor prognostic factors. Median survival without treatment is <8 months from the moment of its presentation, and a survival rate at 5 years of 11% is the best prognosis for those who present with local metastasis. Even in patients with limited metastatic disease, 5-year survival is exceptional. Patients with hepatic metastasis of colorectal cancer have a median survival of 5 to 20 months with no treatment. Approximately 20 to 30% of patients with colorectal metastasis have disease confined to the liver, and this can be managed with surgery. Modern surgical strategies at the main hepatobiliary centers have proved that hepatectomy of 70% of the liver can be performed, with a mortality rate of <5%. It is very important to have knowledge of predisposing factors, diagnostic methods, and treatment of hepatic metastasis. However, the establishment of newer, efficient, preventive screening programs for early diagnosis and adequate treatment is vital. How to cite this article: Valderrama-Treviño AI, Barrera-Mera B, Ceballos-Villalva JC, Montalvo-Javé EE. Hepatic Metastasis from Colorectal Cancer. Euroasian J Hepato-Gastroenterol 2017;7(2):166-175.
Case Reports in Gastroenterology | 2008
Eduardo E. Montalvo-Javé; Eduardo Alegre-Tamez; César Athié-Gutiérrez
Gallstone ileus is a rare cause of small bowel obstruction which usually presents in elderly female patients and which has been associated with high morbidity and mortality rates. We present the case of a 63-year-old man who presented at our institution with symptoms of bowel obstruction. Abdominal X-ray and exploratory laparotomy revealed a large gallstone in the terminal ileus.
Cirugia Y Cirujanos | 2011
Eduardo E. Montalvo-Javé; Corres-Sillas O; César Athié-Gutiérrez
Cirugia Y Cirujanos | 2011
Eduardo E. Montalvo-Javé; Omar Corres-Sillas; César Athié-Gutiérrez
Cirugia Y Cirujanos | 2011
Eduardo E. Montalvo-Javé; Marco Antonio García-Puig; Tomás Escalante-Tattersfield; Julieta Peña-Sánchez; Héctor Vázquez-Meza; Jose A. Ortega-Salgado
Cirujano General | 2008
Heriberto Rodea-Rosas; César Athié-Gutiérrez; Marco Antonio Durán Padilla; Eduardo E. Montalvo-Javé; Clemente Guizae-Bermúdez
Revista Médica del Hospital General de México | 2013
Eduardo E. Montalvo-Javé; Luis H. Toledo-Pereyra; Óscar Chapa-Azuela